ArticleThe Journal of infectious diseases2026

Balancing Pharmacokinetic Targets and Lymphocyte Declines with Once-Monthly Oral Islatravir for PrEP.

Anxin WenPubMed ↗Publisher ↗

No numbers read from the abstract.